These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler. Anzola GP Eur J Ultrasound; 2002 Nov; 16(1-2):11-20. PubMed ID: 12470846 [TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
5. Five-year experience with percutaneous closure of patent foramen ovale. Slavin L; Tobis JM; Rangarajan K; Dao C; Krivokapich J; Liebeskind DS Am J Cardiol; 2007 May; 99(9):1316-20. PubMed ID: 17478165 [TBL] [Abstract][Full Text] [Related]
6. Migraine headache relief after transcatheter closure of patent foramen ovale. Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692 [TBL] [Abstract][Full Text] [Related]
7. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke. West BH; Noureddin N; Mamzhi Y; Low CG; Coluzzi AC; Shih EJ; Gevorgyan Fleming R; Saver JL; Liebeskind DS; Charles A; Tobis JM Stroke; 2018 May; 49(5):1123-1128. PubMed ID: 29636424 [TBL] [Abstract][Full Text] [Related]
15. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder. Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463 [TBL] [Abstract][Full Text] [Related]
16. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921 [TBL] [Abstract][Full Text] [Related]
17. [Percutaneous closure of patent foramen ovale: a wise approach]. Gaspardone A; Iani C; Papa M G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080 [TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced transthoracic echocardiography applied in evaluation of pulmonary right-to-left shunt: A preliminary study. Feng C; Luo T; Luo Y; Zhao N; Huang K; Xiao C Comput Med Imaging Graph; 2018 Sep; 68():55-60. PubMed ID: 30056290 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM; Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434 [TBL] [Abstract][Full Text] [Related]
20. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Steiner MM; Di Tullio MR; Rundek T; Gan R; Chen X; Liguori C; Brainin M; Homma S; Sacco RL Stroke; 1998 May; 29(5):944-8. PubMed ID: 9596240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]